PHA-30010 - MPharm Programme Stage 3
Coordinator: Katie Maddock Room: HORBM1.14 Tel: +44 1782 7 34789
Lecture Time: See Timetable...
Level: Level 6
Credits: 120
Study Hours: 1200
School Office:

Programme/Approved Electives for 2022/23

None

Available as a Free Standing Elective

No

Co-requisites

None

Prerequisites

None

Barred Combinations

None

Description for 2022/23

Stage 3 of the MPharm programme has been consolidated into one single 120-credit unit, enabling a continuum of learning that is centred upon the development of key clinical and therapeutic skills. Teaching of therapeutic areas will be fully integrated by inclusion of key pharmacological, chemical and pharmaceutical information related to the subject areas being studied. By the end of Stage 3, MPharm students should be prepared as fully as possible to undertake any summer vacation placements and interviews for pre-registration placements.

Aims
This module aims to further develop students core skills in relation to the practice and science of pharmacy in the context of clinical care of patients. Students will also be enabled to explore specialisms within pharmacy, including research and sector-specific practice.

Talis Aspire Reading List
Any reading lists will be provided by the start of the course.
http://lists.lib.keele.ac.uk/modules/pha-30010/lists

Intended Learning Outcomes

Apply a detailed understanding of the statistical and mathematical tools of evidence-based medicine, including epidemiology, to calculate, analyse and draw conclusions from the results of clinical trials and epidemiological studies: 1,2,3,4,5,6,7
Use the principles of evidence-based medicine and systematically apply knowledge of the underpinning pharmaceutical sciences to the process of therapeutic decision making in the management of specified disease states: 1,2,3,4,5,6,7
Demonstrate knowledge of and apply an integrated approach towards patient care which links pharmaceutical science and
pharmacy practice: 1,2,3,4,5,6,7
Apply a systematic and integrated knowledge of underpinning pharmaceutical sciences and pharmaceutical care to the
interpretation and implementation of clinical and therapeutic guidelines: 1,2,3,4,5,6,7
Review, consolidate and extend knowledge and understanding of the properties and applications of drug delivery systems to
maximise the therapeutic benefits for patients: 1,2,3,4,5,6,7
Review, consolidate and extend knowledge and understanding of microbiology, medicinal chemistry, pharmacology and
pharmaceutics in the context of pharmaceutical care and medicines optimisation: 1,2,3,4,5,6,7
Describe and critically evaluate the role of pharmacotherapy in the management of specifed disease states: 1,2,3,4,5,6,7
Develop an understanding of the causes, incidence and clinical features, including differential diagnosis, of specified disease states: 1,2,3,4,5,6,7
Apply a systematic and integrated knowledge of underpinning pharmaceutical sciences to the process of therapeutic decision
making in specific population groups, including: children, the elderly, pregnant women and breastfeeding mothers, patients with liver and renal impairment: 1,2,3,4,5,6,7
Critically evaluate medical case notes (including laboratory data) as part of a multidisciplinary healthcare team: 1,2,3,4,5,6,7
Review, consolidate and extend knowledge of the legal, regulatory and governance frameworks of pharmacy practice: 1,2,3,4,5,6,7
Review, consolidate and extend knowledge of the regulation of healthcare professions, including fitness to practise: 1,2,3,4,5,6,7
Demonstrate a systematic understanding of the concepts of public health, health inequalities and health promotion (including the legal and professional framework for accountability) needed to implement and evaluate a health promotion campaign: 1,2,3,4,5,6,7
Apply an in-depth knowledge of decision making processes to complex ethical problems
: 1,2,3,4,5,6,7
Compare and critically evaluate research techniques and self-management skills in order to plan a programme of research at a professional level: 1,2,3,4,5,6,7
Identify and explain the differences between audit, service evaluation and research
: 1,2,3,4,5,6,7
Critically evaluate current research and advanced scholarship in pharmacy, the pharmaceutical sciences and related fields, and
apply a detailed understanding of the research process in planning a research project: 1,2,3,4,5,6,7
Demonstrate an ability to make informed decisions using the available evidence base to solve complex problems: 1,2,3,4,5,6,7
Demonstrate competence in calculations related to evidence-based medicine, clinical pharmacy and pharmaceutics: 1,2,3,4,5,6,7
Communicate complex concepts effectively, both orally and in writing, in a manner that reflects professional practice: 1,2,3,4,5,6,7

Study hours

The module comprises a rich mixture of different teaching styles, broadly in the following proportions:
Large and small-group teaching sessions: 250 hours
Skills-based practical work and placement activity: 100 hours
Directed private study: 400 hours
Non-directed private study, revision and assessment: 450 hours

School Rules

None

Description of Module Assessment

1: Coursework weighted 15%
Stage 3 Coursework part 1
This component of assessment comprises a variety of assessments including: case studies and critiques.

2: Coursework weighted 15%
Stage 3 Coursework part 2
This component of assessment comprises a variety of assessments including: case studies, on-line group work, OSPEs and TRIPSEs.

3: Coursework weighted 20%
Stage 3 Coursework part 3
Students will be assessed by form of a research proposal in an area of research chosen by tutor and student (90% of this component). Low stakes assessments (LSAs) will make up the remaining 10% of this component. There will be five small engagement tasks of equal weighting (2%). These LSAs will total 2% of the overall stage 3 module mark.

4: Mixed Exam weighted 25%
Stage 3 Examination 1 (2 papers)
This examination comprises both seen and unseen elements and will contain a combination of MCQs and written answers presented as two papers.

5: Mixed Exam weighted 25%
Stage 3 Examination 2 (2 papers)
This examination comprises both seen and unseen elements and will contain a combination of MCQs and written answers presented as two papers.

6: Mixed Exam weighted 0%
End of year synoptic assessment
This assessment will comprise both group work and individual assessment. It will potentially cover all topics studied during the year, but will focus in particular on demonstrating understanding of the integration of those topics.

7: Professional Development weighted 0%
Professional skills development
The Professional Development assessment will include CPD activities, competency assessment in pharmacy practice (including calculations and communications skills), case studies in ethics, and evidence of professionalism measured by Professional Activity Credits.